A chronic hepatitis B identification and surveillance program improves care in an integrated health plan

Optimal management of patients with chronic hepatitis B (CHB) requires surveillance for hepatocellular carcinoma (HCC) and identification of antiviral-therapy candidates, but few dedicated CHB-surveillance models have been described. Kaiser Permanente Northern California (KPNC) developed a systematic CHB surveillance-and-management program in 2012. We report the results of the program's performance over the initial 8-year period.